| Bermuda | 001-34717 | 77-0553536 | ||||||||||||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
||||||||||||
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||||
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
||||||
| Common Shares | AOSL | The NASDAQ Global Select Market | ||||||
| Alpha and Omega Semiconductor Limited | ||||||||
| By: | /s/ Yifan Liang | |||||||
| Name: | Yifan Liang | |||||||
| Title: | Chief Financial Officer and Corporate Secretary | |||||||
| GAAP Financial Comparison | ||||||||||||||||||||
| Quarterly | ||||||||||||||||||||
| (in millions, except percentage and per share data) | ||||||||||||||||||||
| (unaudited) | ||||||||||||||||||||
| Three Months Ended | ||||||||||||||||||||
| June 30, 2025 | March 31, 2025 | June 30, 2024 | ||||||||||||||||||
| Revenue | $ | 176.5 | $ | 164.6 | $ | 161.3 | ||||||||||||||
| Gross Margin | 23.4 | % | 21.4 | % | 25.7 | % | ||||||||||||||
| Operating Loss | $ | (11.6) | $ | (10.7) | $ | (1.5) | ||||||||||||||
| Net Loss | $ | (77.1) | $ | (10.8) | $ | (2.7) | ||||||||||||||
| Net Loss Per Share - Diluted | $ | (2.58) | $ | (0.37) | $ | (0.09) | ||||||||||||||
| Non-GAAP Financial Comparison | ||||||||||||||||||||
| Quarterly | ||||||||||||||||||||
| (in millions, except percentage and per share data) | ||||||||||||||||||||
| (unaudited) | ||||||||||||||||||||
| Three Months Ended | ||||||||||||||||||||
| June 30, 2025 | March 31, 2025 | June 30, 2024 | ||||||||||||||||||
| Revenue | $ | 176.5 | $ | 164.6 | $ | 161.3 | ||||||||||||||
| Non-GAAP Gross Margin | 24.4 | % | 22.5 | % | 26.4 | % | ||||||||||||||
| Non-GAAP Operating Income (Loss) | $ | 2.3 | $ | (2.7) | $ | 3.2 | ||||||||||||||
| Non-GAAP Net Income (Loss) | $ | 0.7 | $ | (2.9) | $ | 2.6 | ||||||||||||||
| Non-GAAP Net Income (Loss) Per Share - Diluted | $ | 0.02 | $ | (0.10) | $ | 0.09 | ||||||||||||||
| GAAP Financial Comparison | ||||||||||||||||||||
| Annually | ||||||||||||||||||||
| (in millions, except percentage and per share data) | ||||||||||||||||||||
| (unaudited) | ||||||||||||||||||||
| Year Ended June 30, | ||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||
| Revenue | $ | 696.2 | $ | 657.3 | ||||||||||||||||
| Gross Margin | 23.1 | % | 26.2 | % | ||||||||||||||||
| Operating Loss | $ | (28.4) | $ | (3.8) | ||||||||||||||||
| Net Loss | $ | (97.0) | $ | (11.1) | ||||||||||||||||
Net Loss Per Share - Diluted |
$ | (3.30) | $ | (0.39) | ||||||||||||||||
| Non-GAAP Financial Comparison | ||||||||||||||||||||
| Annually | ||||||||||||||||||||
| (in millions, except percentage and per share data) | ||||||||||||||||||||
| (unaudited) | ||||||||||||||||||||
| Year Ended June 30, | ||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||
| Revenue | $ | 696.2 | $ | 657.3 | ||||||||||||||||
| Non-GAAP Gross Margin | 24.2 | % | 27.2 | % | ||||||||||||||||
| Non-GAAP Operating Income | $ | 10.4 | $ | 21.7 | ||||||||||||||||
| Non-GAAP Net Income | $ | 7.0 | $ | 18.5 | ||||||||||||||||
Non-GAAP Net Income Per Share - Diluted |
$ | 0.22 | $ | 0.62 | ||||||||||||||||
| Alpha and Omega Semiconductor Limited | |||||||||||||||||||||||||||||
| Condensed Consolidated Statements of Operations | |||||||||||||||||||||||||||||
| (in thousands, except percentages and per share amounts) | |||||||||||||||||||||||||||||
| (unaudited) | |||||||||||||||||||||||||||||
| Three Months Ended | Fiscal Year Ended | ||||||||||||||||||||||||||||
| June 30, 2025 |
March 31, 2025 | June 30, 2024 | June 30, 2025 | June 30, 2024 | |||||||||||||||||||||||||
| Revenue | $ | 176,484 | $ | 164,635 | $ | 161,296 | $ | 696,162 | $ | 657,274 | |||||||||||||||||||
| Cost of goods sold | 135,194 | 129,458 | 119,859 | 535,158 | 485,356 | ||||||||||||||||||||||||
| Gross profit | 41,290 | 35,177 | 41,437 | 161,004 | 171,918 | ||||||||||||||||||||||||
| Gross margin | 23.4 | % | 21.4 | % | 25.7 | % | 23.1 | % | 26.2 | % | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||||||||
| Research and development | 24,421 | 23,398 | 21,813 | 94,265 | 89,940 | ||||||||||||||||||||||||
| Selling, general and administrative | 28,487 | 22,437 | 21,123 | 95,175 | 85,734 | ||||||||||||||||||||||||
| Total operating expenses | 52,908 | 45,835 | 42,936 | 189,440 | 175,674 | ||||||||||||||||||||||||
| Operating loss | (11,618) | (10,658) | (1,499) | (28,436) | (3,756) | ||||||||||||||||||||||||
| Other income (loss), net | (952) | (65) | 65 | (1,004) | (73) | ||||||||||||||||||||||||
| Interest income | 956 | 927 | 1,295 | 4,283 | 5,168 | ||||||||||||||||||||||||
| Interest expenses | (530) | (596) | (883) | (2,639) | (3,982) | ||||||||||||||||||||||||
| Gain on change of equity interest in equity method investment | — | 505 | — | 505 | — | ||||||||||||||||||||||||
| Impairment of equity method investment | (76,784) | — | — | (76,784) | — | ||||||||||||||||||||||||
| Net loss before income tax expense (benefit) and income (loss) from equity method investment | (88,928) | (9,887) | (1,022) | (104,075) | (2,643) | ||||||||||||||||||||||||
| Income tax expense (benefit) | (11,567) | 660 | 1,006 | (8,625) | 3,649 | ||||||||||||||||||||||||
| Net loss before income (loss) from equity method investment | (77,361) | (10,547) | (2,028) | (95,450) | (6,292) | ||||||||||||||||||||||||
| Equity method investment income (loss) from equity investee | 302 | (260) | (704) | (1,526) | (4,789) | ||||||||||||||||||||||||
| Net loss | $ | (77,059) | $ | (10,807) | $ | (2,732) | $ | (96,976) | $ | (11,081) | |||||||||||||||||||
| Net loss per common share | |||||||||||||||||||||||||||||
| Basic | $ | (2.58) | $ | (0.37) | $ | (0.09) | $ | (3.30) | $ | (0.39) | |||||||||||||||||||
| Diluted | $ | (2.58) | $ | (0.37) | $ | (0.09) | $ | (3.30) | $ | (0.39) | |||||||||||||||||||
| Weighted average number of common shares used to compute net loss per share: | |||||||||||||||||||||||||||||
| Basic | 29,924 | 29,530 | 28,879 | 29,405 | 28,236 | ||||||||||||||||||||||||
| Diluted | 29,924 | 29,530 | 28,879 | 29,405 | 28,236 | ||||||||||||||||||||||||
| Alpha and Omega Semiconductor Limited | |||||||||||
| Condensed Consolidated Balance Sheets | |||||||||||
| (in thousands, except par value per share) | |||||||||||
| (unaudited) | |||||||||||
| June 30, 2025 | June 30, 2024 | ||||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 153,079 | $ | 175,127 | |||||||
| Restricted cash | 419 | 413 | |||||||||
| Accounts receivable, net | 34,772 | 12,546 | |||||||||
| Inventories | 189,677 | 195,750 | |||||||||
| Other current assets | 16,604 | 14,165 | |||||||||
| Total current assets | 394,551 | 398,001 | |||||||||
| Property, plant and equipment, net | 314,097 | 336,619 | |||||||||
| Operating lease right-of-use assets, net | 21,288 | 25,050 | |||||||||
| Intangible assets, net | 269 | 3,516 | |||||||||
| Equity method investment | 279,122 | 356,039 | |||||||||
| Deferred income tax assets | 599 | 549 | |||||||||
| Other long-term assets | 22,766 | 25,239 | |||||||||
| Total assets | $ | 1,032,692 | $ | 1,145,013 | |||||||
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 60,044 | $ | 45,084 | |||||||
| Accrued liabilities | 57,416 | 72,371 | |||||||||
| Payable related to equity investee, net | 15,809 | 13,682 | |||||||||
| Income taxes payable | 1,790 | 2,798 | |||||||||
| Short-term debt | 11,852 | 11,635 | |||||||||
| Deferred revenue | — | 2,591 | |||||||||
| Finance lease liabilities | 1,007 | 935 | |||||||||
| Operating lease liabilities | 4,978 | 5,137 | |||||||||
| Total current liabilities | 152,896 | 154,233 | |||||||||
| Long-term debt | 14,872 | 26,724 | |||||||||
| Income taxes payable - long-term | 4,201 | 3,591 | |||||||||
| Deferred income tax liabilities | 13,192 | 26,416 | |||||||||
| Finance lease liabilities - long-term | 1,274 | 2,282 | |||||||||
| Operating lease liabilities - long-term | 16,925 | 20,499 | |||||||||
| Other long-term liabilities | 7,000 | 19,661 | |||||||||
| Total liabilities | 210,360 | 253,406 | |||||||||
Commitments and contingencies |
|||||||||||
| Shareholders' Equity: | |||||||||||
| Preferred shares, par value $0.002 per share: | |||||||||||
| Authorized: 10,000 shares; issued and outstanding: none at June 30, 2025 and 2024 | — | — | |||||||||
| Common shares, par value $0.002 per share: | |||||||||||
| Authorized: 100,000 shares; issued and outstanding: 37,127 shares and 30,009 shares, respectively at June 30, 2025 and 36,107 shares and 28,969 shares, respectively at June 30, 2024 | 74 | 72 | |||||||||
| Treasury shares at cost; 7,118 shares at June 30, 2025 and 7,138 shares at June 30, 2024 | (79,058) | (79,213) | |||||||||
| Additional paid-in capital | 379,779 | 353,109 | |||||||||
| Accumulated other comprehensive loss | (12,390) | (13,419) | |||||||||
| Retained earnings | 533,927 | 631,058 | |||||||||
| Total shareholders' equity | 822,332 | 891,607 | |||||||||
| Total liabilities and shareholders' equity | $ | 1,032,692 | $ | 1,145,013 | |||||||
| Alpha and Omega Semiconductor Limited | |||||||||||
| Selected Cash Flow Information | |||||||||||
(in thousands) | |||||||||||
| (unaudited) | |||||||||||
Fiscal Year Ended June 30, |
|||||||||||
| 2025 | 2024 | ||||||||||
| Net cash provided by operating activities | $ | 29,668 | $ | 25,710 | |||||||
| Net cash used in investing activities | (36,441) | (35,744) | |||||||||
| Net cash used in financing activities | (15,496) | (9,903) | |||||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 227 | (126) | |||||||||
| Net decrease in cash, cash equivalents and restricted cash | (22,042) | (20,063) | |||||||||
| Cash, cash equivalents and restricted cash at beginning of year | 175,540 | 195,603 | |||||||||
| Cash, cash equivalents and restricted cash at end of year | $ | 153,498 | $ | 175,540 | |||||||
| Alpha and Omega Semiconductor Limited | |||||||||||||||||||||||||||||
| Reconciliation of Condensed Consolidated GAAP Financial Measures to Non-GAAP Financial Measures | |||||||||||||||||||||||||||||
| (in thousands, except percentages and per share data) | |||||||||||||||||||||||||||||
| (unaudited) | |||||||||||||||||||||||||||||
Three Months Ended |
Fiscal Year Ended |
||||||||||||||||||||||||||||
| June 30, 2025 |
March 31, 2025 |
June 30, 2024 |
June 30, 2025 |
June 30, 2024 |
|||||||||||||||||||||||||
| GAAP gross profit | $ | 41,290 | $ | 35,177 | $ | 41,437 | $ | 161,004 | $ | 171,918 | |||||||||||||||||||
| Share-based compensation | 1,039 | 1,047 | 294 | 4,224 | 3,434 | ||||||||||||||||||||||||
| Amortization of purchased intangible | 811 | 812 | 812 | 3,247 | 3,247 | ||||||||||||||||||||||||
| Non-GAAP gross profit | $ | 43,140 | $ | 37,036 | $ | 42,543 | $ | 168,475 | $ | 178,599 | |||||||||||||||||||
| Non-GAAP gross margin as a % of revenue | 24.4 | % | 22.5 | % | 26.4 | % | 24.2 | % | 27.2 | % | |||||||||||||||||||
| GAAP operating expense | $ | 52,908 | $ | 45,835 | $ | 42,936 | $ | 189,440 | $ | 175,674 | |||||||||||||||||||
| Share-based compensation | 6,542 | 6,089 | 3,273 | 25,345 | 18,207 | ||||||||||||||||||||||||
Settlement and legal costs related to government investigation |
4,461 | 54 | 352 | 4,977 | 524 | ||||||||||||||||||||||||
| Impairment of long-lived assets | 1,045 | — | — | 1,045 | — | ||||||||||||||||||||||||
| Non-GAAP operating expense | $ | 40,860 | $ | 39,692 | $ | 39,311 | $ | 158,073 | $ | 156,943 | |||||||||||||||||||
| GAAP operating loss | $ | (11,618) | $ | (10,658) | $ | (1,499) | $ | (28,436) | $ | (3,756) | |||||||||||||||||||
| Share-based compensation | 7,581 | 7,136 | 3,567 | 29,569 | 21,641 | ||||||||||||||||||||||||
| Amortization of purchased intangible | 811 | 812 | 812 | 3,247 | 3,247 | ||||||||||||||||||||||||
Settlement and legal costs related to government investigation |
4,461 | 54 | 352 | 4,977 | 524 | ||||||||||||||||||||||||
| Impairment of long-lived assets | 1,045 | — | — | 1,045 | — | ||||||||||||||||||||||||
| Non-GAAP operating income (loss) | $ | 2,280 | $ | (2,656) | $ | 3,232 | $ | 10,402 | $ | 21,656 | |||||||||||||||||||
| Non-GAAP operating margin as a % of revenue | 1.3 | % | (1.6) | % | 2.0 | % | 1.5 | % | 3.3 | % | |||||||||||||||||||
| GAAP net loss | $ | (77,059) | $ | (10,807) | $ | (2,732) | $ | (96,976) | $ | (11,081) | |||||||||||||||||||
| Share-based compensation | 7,581 | 7,136 | 3,567 | 29,569 | 21,641 | ||||||||||||||||||||||||
| Amortization of purchased intangible | 811 | 812 | 812 | 3,247 | 3,247 | ||||||||||||||||||||||||
| Gain on change of equity interest in equity method investment | — | (505) | — | (505) | — | ||||||||||||||||||||||||
| Equity method investment loss (gain) from equity investee | (302) | 260 | 704 | 1,526 | 4,789 | ||||||||||||||||||||||||
Settlement and legal costs related to government investigation |
4,461 | 54 | 352 | 4,977 | 524 | ||||||||||||||||||||||||
Impairment of equity method investment |
76,784 | — | — | 76,784 | — | ||||||||||||||||||||||||
| Impairment of long-lived assets | 1,045 | — | — | 1,045 | — | ||||||||||||||||||||||||
| Income tax effect of non-GAAP adjustments | (12,584) | 148 | (78) | (12,670) | (627) | ||||||||||||||||||||||||
| Non-GAAP net income (loss) | $ | 737 | $ | (2,902) | $ | 2,625 | $ | 6,997 | $ | 18,493 | |||||||||||||||||||
| Non-GAAP net margin as a % of revenue | 0.4 | % | (1.8) | % | 1.6 | % | 1.0 | % | 2.8 | % | |||||||||||||||||||
| GAAP net loss | $ | (77,059) | $ | (10,807) | $ | (2,732) | $ | (96,976) | $ | (11,081) | |||||||||||||||||||
| Share-based compensation | 7,581 | 7,136 | 3,567 | 29,569 | 21,641 | ||||||||||||||||||||||||
| Amortization and depreciation | 15,447 | 18,259 | 13,908 | 62,396 | 53,757 | ||||||||||||||||||||||||
| Equity method investment loss (gain) from equity investee | (302) | 260 | 704 | 1,526 | 4,789 | ||||||||||||||||||||||||
| Impairment of equity method investment | 76,784 | — | — | 76,784 | — | ||||||||||||||||||||||||
| Interest income | (956) | (927) | (1,295) | (4,283) | (5,168) | ||||||||||||||||||||||||
| Interest expense | 530 | 596 | 883 | 2,639 | 3,982 | ||||||||||||||||||||||||
| Income tax expense (benefit) | (11,567) | 660 | 1,006 | (8,625) | 3,649 | ||||||||||||||||||||||||
| EBITDAS | $ | 10,458 | $ | 15,177 | $ | 16,041 | $ | 63,030 | $ | 71,569 | |||||||||||||||||||
| GAAP diluted net loss per share | $ | (2.49) | $ | (0.37) | $ | (0.09) | $ | (3.10) | $ | (0.37) | |||||||||||||||||||
| Share-based compensation | 0.25 | 0.24 | 0.12 | 0.95 | 0.72 | ||||||||||||||||||||||||
| Amortization of purchased intangible | 0.03 | 0.03 | 0.03 | 0.10 | 0.11 | ||||||||||||||||||||||||
| Gain on change of equity interest in equity method investment | — | (0.02) | — | (0.02) | — | ||||||||||||||||||||||||
| Equity method investment loss (gain) from equity investee | (0.01) | 0.01 | 0.02 | 0.05 | 0.16 | ||||||||||||||||||||||||
Settlement and legal costs related to government investigation |
0.14 | 0.00 | 0.01 | 0.16 | 0.02 | ||||||||||||||||||||||||
| Impairment of equity method investment | 2.48 | — | — | 2.46 | — | ||||||||||||||||||||||||
| Impairment of long-lived assets | 0.03 | — | — | 0.03 | — | ||||||||||||||||||||||||
| Income tax effect of non-GAAP adjustments | (0.41) | 0.01 | (0.00) | (0.41) | (0.02) | ||||||||||||||||||||||||
| Non-GAAP diluted net income (loss) per share | $ | 0.02 | $ | (0.10) | $ | 0.09 | $ | 0.22 | $ | 0.62 | |||||||||||||||||||
| Weighted average number of common shares used to compute GAAP diluted net income (loss) per share | 29,924 | 29,530 | 28,879 | 29,405 | 28,236 | ||||||||||||||||||||||||
| Weighted average number of common shares used to compute Non-GAAP diluted net income (loss) per share | 31,009 | 29,530 | 30,463 | 31,239 | 30,052 | ||||||||||||||||||||||||
| Alpha and Omega Semiconductor Limited | ||||||||||||||||||||||||||
| Reconciliation of GAAP to Non-GAAP Outlook | ||||||||||||||||||||||||||
| For Fiscal Q1 Ending September 30, 2025 | ||||||||||||||||||||||||||
| (in millions, except percentages) | ||||||||||||||||||||||||||
| GAAP gross margin | 23.8 | % | ||||||||||||||||||||||||
| Estimated impact of share-based compensation expense | 0.6 | % | ||||||||||||||||||||||||
| Non-GAAP gross margin | 24.4 | % | ||||||||||||||||||||||||
| GAAP operating expenses | $ | 47.5 | ||||||||||||||||||||||||
| Estimated stock-based compensation expense | (6.5) | |||||||||||||||||||||||||
| Non-GAAP operating expenses | $ | 41.0 | ||||||||||||||||||||||||